Annalise.ai wins ‘Best New Radiology Vendor’ in prestigious Minnies Awards

Press release: Australian healthtech leader Annalise.ai releases next-generation CT Brain AI solution for clinical use in Australia, New Zealand and the UK

Annalise Enterprise CXR granted CE Mark under MDR class IIb for clinical use in EU

Annalise Enterprise CXR Named “Best New Radiology Solution” in 2022 MedTech Breakthrough Awards Program

NHS Grampian the first healthcare provider in the UK to evaluate Annalise Enterprise

Annalise Enterprise CXR receives first U.S. FDA 510(k) clearance

Annalise CXR is CE marked for use in the UK and Europe